Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
HRMY - Harmony Biosciences Holdings, I
Market Cap 1.95B P/E 10.47 EPS this Y 42.30% Ern Qtrly Grth -45.20%
Income 128.85M Forward P/E 9.90 EPS next Y 37.30% 50D Avg Chg -8.00%
Sales 582.02M PEG 0.40 EPS past 5Y 37.30% 200D Avg Chg -26.00%
Dividend N/A Price/Book 4.03 EPS next 5Y 23.80% 52W High Chg -48.00%
Recommedations 2.40 Quick Ratio 2.61 Shares Outstanding 56.77M 52W Low Chg 9.00%
Insider Own 19.77% ROA 16.16% Shares Float 34.62M Beta 0.73
Inst Own 90.20% ROE 29.63% Shares Shorted/Prior 6.46M/6.09M Price 32.56
Gross Margin 79.17% Profit Margin 22.14% Avg. Volume 465,361 Target Price 41.50
Oper. Margin 23.87% Earnings Date Apr 30 Volume 863,927 Change -4.21%
Healthcare | Biotechnology | United States
About Harmony Biosciences Holdings, I

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

Harmony Biosciences Holdings, I News
04/16/24 HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024
04/11/24 HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST
04/03/24 HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME
03/26/24 HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE
03/19/24 Harmony Biosciences Holdings Inc's Chief Commercial Officer Sells Company Shares
03/08/24 10 Biotech Stocks with Huge Potential
02/28/24 HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
02/23/24 Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q4 2023 Earnings Call Transcript
02/23/24 HRMY vs. TECH: Which Stock Is the Better Value Option?
02/22/24 Q4 2023 Harmony Biosciences Holdings Inc Earnings Call
02/22/24 Harmony Biosciences (HRMY) Q4 2023 Earnings Call Transcript
02/22/24 Harmony Biosciences Holdings, Inc. (HRMY) Misses Q4 Earnings and Revenue Estimates
02/22/24 Harmony Biosciences Holdings Inc (HRMY) Reports Robust Revenue Growth in Q4 and Full Year 2023
02/22/24 Harmony Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Business Updates
02/21/24 U.S. FOOD AND DRUG ADMINISTRATION GRANTS PRIORITY REVIEW TO HARMONY BIOSCIENCES' APPLICATION FOR WAKIX® (PITOLISANT) IN PEDIATRIC NARCOLEPSY
02/20/24 HARMONY BIOSCIENCES RECEIVES U.S. FOOD AND DRUG ADMINISTRATION ORPHAN DRUG DESIGNATION FOR PITOLISANT IN PRADER-WILLI SYNDROME
02/12/24 The 3 Most Undervalued Small-Cap Stocks to Buy in February 2024
02/08/24 HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 22, 2024
02/07/24 The 3 Most Undervalued Russell 2000 Stocks to Buy in February 2024
02/07/24 HRMY or ILMN: Which Is the Better Value Stock Right Now?
HRMY Chatroom

User Image Tom1985IT Posted - 1 week ago

$HRMY I hope that Orexin 2 agonist you just acquired different have the toxicity issues Takeda, Alkermes and Jazz are currently dealing with!!

User Image Stock_Titan Posted - 1 week ago

$HRMY HARMONY BIOSCIENCES TO REPORT FIRST QUARTER 2024 FINANCIAL RESULTS ON APRIL 30, 2024 https://www.stocktitan.net/news/HRMY/harmony-biosciences-to-report-first-quarter-2024-financial-results-b5go7jdla6kz.html

User Image footlsfoot Posted - 1 week ago

$HRMY oxybates sucks

User Image UncleStock Posted - 1 week ago

$HRMY $CPRX $REGN suggested for #raremetals - value screen: https://zpr.io/g2sfw

User Image tradingtwenty Posted - 2 weeks ago

$HRMY has trended 4 times in the past 24 hours (based on 5 minute intervals). Latest press release on Apr 11, 2024 08:05 AM: HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND... Link: https://tradingtwenty.com/news/425541/harmony-biosciences-announces-exclusive-agreement-to-develop-and-commercialize-tpm-1116-a-highly-potent-and-selective-oral-orexin-2-receptor-agonist

User Image DonCorleone77 Posted - 2 weeks ago

$HRMY Harmony Biosciences signs exclusive licensing agreement for sleeping disorders Harmony Biosciences signed an exclusive licensing agreement with Bioprojet to develop, manufacture and commercialize TPM-1116, a highly potent and selective oral orexin-2 receptor agonist that will be evaluated for the treatment of narcolepsy and other sleep/wake disorders. The agreement will accelerate the development of this orexin-2 receptor agonist. Harmony will pay Bioprojet an upfront license fee of $25.5M for the exclusive right to develop, manufacture and commercialize TPM-1116 in the U.S. and Latin American territories. In addition, Harmony is obligated to pay up to $127.5M upon achievement of development and regulatory milestones and up to $240M upon achievement of sales-based milestones. Finally, Harmony will pay a royalty rate in the mid-teens on sales of product in the licensed territories.

User Image Stock_Titan Posted - 2 weeks ago

$HRMY HARMONY BIOSCIENCES ANNOUNCES EXCLUSIVE AGREEMENT TO DEVELOP AND COMMERCIALIZE TPM-1116, A HIGHLY POTENT AND SELECTIVE ORAL OREXIN-2 RECEPTOR AGONIST https://www.stocktitan.net/news/HRMY/harmony-biosciences-announces-exclusive-agreement-to-develop-and-t8sj81wettj4.html

User Image UncleStock Posted - 2 weeks ago

$SIGA $INVA $VYGR $HRMY suggested for Pharmaceuticals and Biotechnology - value screen: https://zpr.io/NGP6QnBCdEbN

User Image briefingcom Posted - 3 weeks ago

$HRMY: Harmony Biosciences initiates global Phase 3 registrational trial (TEMPOstudy) of pitolisant in patients with Prader-Willi syndrome

User Image Stock_Titan Posted - 3 weeks ago

$HRMY HARMONY BIOSCIENCES INITIATES GLOBAL PHASE 3 REGISTRATIONAL TRIAL (TEMPO STUDY) OF PITOLISANT IN PATIENTS WITH PRADER-WILLI SYNDROME https://www.stocktitan.net/news/HRMY/harmony-biosciences-initiates-global-phase-3-registrational-trial-z1d11ru4zd10.html

User Image Doozio Posted - 03/29/24

It was always 2020FOUR when chop chop huckleberries wud happen in $hrmy with 🧠⏰♾️😇📦 n expose all da bum 🐑

User Image UncleStock Posted - 03/28/24

$SIGA $INVA $VYGR $HRMY suggested for $NBI US NASDAQ Biotechnology - value screen: https://zpr.io/tBVec

User Image erevnon Posted - 03/28/24

Cantor Fitzgerald reiterates Harmony Biosciences $HRMY at Overweight and maintains a price target of https://marketsblock.com/stock-upgrades-and-downgrades/

User Image Nosh Posted - 4 weeks ago

$HRMY Another solid one...

User Image Doozio Posted - 1 month ago

Chop chop n 🧠⏰ shall come in $hrmy with da huckleberries.

User Image Quantumup Posted - 1 month ago

Citi raised PT $AXSM $127 was $125/Buy+⬆️AXS-12 PoS 80%was50%: Says, +VE Ph3 narcolepsy data was met by an unwarranted selloff; sees AXS-12 as approvable/if approved, Co s/b able2leverage existing Sunosi team2commercialize; AXS-12=minor part of thesis=est $310M peak US rev: $jazz $hrmy $abbv $bmy

User Image WhosYourDaddy_ Posted - 1 month ago

$NVAX Does it make you wonder why our clown CEO John Jacobs left $HRMY, which has a market cap of almost $2 billion and trades at around $35.00 per share, to join $NOVASCAM? This question is on behalf of my friend, who is also a bag holder.

User Image WhosYourDaddy_ Posted - 1 month ago

$HRMY DO you guys want your old POS Ceo JJ back $NVAX ?

User Image Stock_Titan Posted - 1 month ago

$HRMY HARMONY BIOSCIENCES TO PARTICIPATE IN 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE https://www.stocktitan.net/news/HRMY/harmony-biosciences-to-participate-in-23rd-annual-needham-virtual-kcjdxyerxgqm.html

User Image UncleStock Posted - 1 month ago

$SIGA $INVA $VYGR $HRMY suggested for $NBI US NASDAQ Biotechnology - value screen: https://zpr.io/tBVec

User Image UncleStock Posted - 1 month ago

$HRMY $CPRX $REGN suggested for #raremetals - value screen: https://zpr.io/g2sfw

User Image insiderbuyingselling Posted - 1 month ago

$HRMY new insider selling: 11979 shares. http://insiderbuyingselling.com/?t=HRMY

User Image UncleStock Posted - 1 month ago

$HRMY $ARCT $REGN suggested for #raremetals - value screen: https://zpr.io/g2sfw

User Image UncleStock Posted - 1 month ago

$INVA $EGRX $HRMY $VNDA suggested for Pharmaceuticals and Biotechnology - value screen: https://zpr.io/NGP6QnBCdEbN

User Image UncleStock Posted - 1 month ago

$HRMY $REGN $ARCT suggested for #raremetals - value screen: https://zpr.io/g2sfw

User Image UncleStock Posted - 1 month ago

$INVA $HRMY $UTHR $VNDA suggested for $NBI US NASDAQ Biotechnology - value screen: https://zpr.io/tBVec

User Image UncleStock Posted - 1 month ago

$HRMY $REGN $ARCT suggested for #raremetals - value screen: https://zpr.io/g2sfw

User Image Shezmezz Posted - 02/29/24

$HRMY i owned shares of zyberna and now it shows zero in my account . what do i do ?

User Image GrayHairGus Posted - 02/29/24

$HRMY sold my position today.

User Image GreenDotStocks Posted - 02/28/24

Updates: HRMY, MELI, SWAV $MELI $SWAV $HRMY https://talkmarkets.com/content/stocks--equities/updates-hrmy-meli-swav?post=434109

Analyst Ratings
Cantor Fitzgerald Overweight Apr 12, 24
Needham Buy Apr 11, 24
Needham Buy Apr 9, 24
Cantor Fitzgerald Overweight Mar 28, 24
Mizuho Buy Feb 27, 24
Cantor Fitzgerald Overweight Feb 23, 24
Needham Buy Feb 23, 24
Needham Buy Feb 22, 24
Mizuho Buy Feb 16, 24
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Nielsen Jack Director Director Dec 14 Sell 59.96 2,834 169,927 2,571,024 12/16/22
Wicki Andreas Director Director Dec 12 Sell 60.16 28,841 1,735,075 2,147,943 12/14/22
Nielsen Jack Director Director Dec 07 Sell 60.05 110,751 6,650,598 2,573,858 12/09/22
Nielsen Jack Director Director Dec 07 Sell 60.05 110,751 6,650,598 2,573,858 12/09/22
Wicki Andreas Director Director Dec 05 Sell 61.23 77,853 4,766,939 2,176,784 12/07/22
Nielsen Jack Director Director Nov 29 Sell 58.92 129,652 7,639,096 2,684,609 12/01/22
Nielsen Jack Director Director Nov 18 Sell 57.23 77,600 4,441,048 2,814,261 11/22/22
Wicki Andreas Director Director Nov 14 Sell 59.6 51,278 3,056,169 2,254,637 11/16/22
Nielsen Jack Director Director Nov 11 Sell 57.55 158,400 9,115,920 2,891,861 11/15/22
Wicki Andreas Director Director Nov 08 Sell 58.95 129,408 7,628,602 2,305,915 11/10/22
Wicki Andreas Director Director Nov 02 Sell 59.02 576,767 34,040,788 2,435,323 11/04/22
Dayno Jeffrey M. CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Nov 01 Option 8.22 15,000 123,300 15,000 11/02/22
Dayno Jeffrey M. CHIEF MEDICAL OFFICE.. CHIEF MEDICAL OFFICER Nov 01 Sell 55.1 15,000 826,500 11/02/22
Wicki Andreas Director Director Aug 08 Sell 53.41 578,552 30,900,462 3,012,090 08/10/22
Nielsen Jack Director Director Aug 04 Sell 52.76 250,000 13,190,000 3,050,261 08/08/22
Wicki Andreas Director Director Aug 03 Sell 52.71 72,586 3,826,008 3,590,642 08/05/22
Nielsen Jack Director Director Jul 18 Sell 55.19 40,087 2,212,402 3,375,378 07/20/22
Nielsen Jack Director Director Jul 13 Sell 55.04 5,773 317,746 3,415,465 07/15/22
Nielsen Jack Director Director Jul 08 Sell 55.04 10,768 592,671 3,421,238 07/12/22
Nielsen Jack Director Director Jul 05 Sell 54.51 300,741 16,393,392 3,432,006 07/07/22
Nielsen Jack Director Director Jun 29 Sell 52.12 14,571 759,441 3,732,747 07/01/22
Nielsen Jack Director Director Jun 24 Sell 52.18 100,463 5,242,159 3,747,318 06/28/22
Nielsen Jack Director Director Apr 21 Sell 52.19 6,554 342,053 3,847,781 04/25/22
Nielsen Jack Director Director Apr 18 Sell 52.21 132,258 6,905,190 3,854,335 04/20/22
Nielsen Jack Director Director Apr 12 Sell 50.9 119,829 6,099,296 3,986,593 04/14/22
Nielsen Jack Director Director Apr 07 Sell 50.17 11,165 560,148 4,093,195 04/11/22
Nielsen Jack Director Director Apr 04 Sell 50.13 21,394 1,072,481 4,102,969 04/06/22
Dierks Jeffrey Chief Commercial Off.. Chief Commercial Officer Apr 01 Option 24 14,471 347,304 14,471 04/05/22
Dierks Jeffrey Chief Commercial Off.. Chief Commercial Officer Apr 01 Sell 49.61 14,471 717,906 04/05/22
Nielsen Jack Director Director Mar 30 Sell 50.13 37,391 1,874,411 4,121,697 04/01/22
Nielsen Jack Director Director Mar 25 Sell 50.65 114,121 5,780,229 4,154,429 03/29/22
Nielsen Jack Director Director Mar 22 Sell 50.17 36,294 1,820,870 4,254,330 03/24/22
Nielsen Jack Director Director Mar 17 Sell 50.08 16,181 810,344 4,286,097 03/21/22
Jacobs John C President, CEO President, CEO Mar 16 Option 8.22 15,000 123,300 15,000 03/18/22
Jacobs John C President, CEO President, CEO Mar 16 Sell 45.32 15,000 679,800 03/18/22
Wicki Andreas Director Director Mar 09 Sell 45.14 285,587 12,891,397 3,663,228 03/11/22
Wicki Andreas Director Director Mar 01 Sell 40.59 596,428 24,209,013 3,948,815 03/04/22
Dierks Jeffrey Chief Commercial Off.. Chief Commercial Officer Feb 16 Option 24 4,459 107,016 200 02/18/22
Dierks Jeffrey Chief Commercial Off.. Chief Commercial Officer Feb 16 Sell 40.03 8,518 340,976 02/18/22
Wicki Andreas Director Director Dec 08 Sell 40.09 27,268 1,093,174 4,545,243 12/10/21
Dayno Jeffrey M. Chief Medical Office.. Chief Medical Officer Oct 19 Option 8.22 18,200 149,604 4,101 10/20/21
Dayno Jeffrey M. Chief Medical Office.. Chief Medical Officer Oct 19 Sell 43.45 18,200 790,790 10/20/21
Dierks Jeffrey Chief Commercial Off.. Chief Commercial Officer Sep 09 Sell 37 5,000 185,000 09/09/21
Dierks Jeffrey Chief Commercial Off.. Chief Commercial Officer Sep 09 Option 8.22 5,000 41,100 5,000 09/09/21
Dayno Jeffrey M. Chief Medical Office.. Chief Medical Officer Sep 09 Sell 37.58 10,000 375,800 09/09/21
Dayno Jeffrey M. Chief Medical Office.. Chief Medical Officer Sep 09 Option 8.22 10,000 82,200 10,000 09/09/21